ACE2 and COVID-19: This process is mediated through the angiotensin-converting-enzyme 2 (ACE2) dependent pathway38,39 Moreover, available evidence suopport that kidney impairment in COVID-19 patients may be caused by an interplay of virus-mediated injury, a dysregulated inflammatory response, hypercoagulation, and microangiopathy40.